Symbols / TLRY Stock $6.75 -2.74% Tilray Brands, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • Canada • NMS
TLRY (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Irwin David Simon
Exch · Country NMS · Canada
Market Cap 807.33M
Enterprise Value 2.94B
Income -1.34B
Sales 858.28M
FCF (ttm) -31.06M
Book/sh 3.02
Cash/sh 0.95
Employees 2,842
Insider 10d —
IPO Jul 19, 2018
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 24.89
PEG —
P/S 0.94
P/B 2.24
P/C —
EV/EBITDA 165.45
EV/Sales 3.42
Quick Ratio 1.31
Current Ratio 2.79
Debt/Eq 63.61
LT Debt/Eq —
EPS (ttm) -14.63
EPS next Y 0.27
EPS Growth —
Revenue Growth -7.80%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-04-01
Earnings (prior) 2026-04-01
ROA -1.47%
ROE -63.16%
ROIC —
Gross Margin 27.68%
Oper. Margin -52.70%
Profit Margin -156.66%
Shs Outstand 119.60M
Shs Float 443.85M
Insider Own 0.73%
Instit Own 10.15%
Short Float 12.44%
Short Ratio 5.11
Short Interest 14.39M
52W High 23.20
vs 52W High -70.91%
52W Low 3.50
vs 52W Low 92.86%
Beta 2.11
Impl. Vol. 91.41%
Rel Volume 2.06
Avg Volume 4.11M
Volume 8.47M
Target (mean) $10.04
Tgt Median $9.00
Tgt Low $6.50
Tgt High $24.00
# Analysts 9
Recom Buy
Prev Close $6.94
Price $6.75
Change -2.74%
About

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the company provides entertainment products. It offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Tilray Craft, Charlotte's Web, Montauk Brewing, Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point Brewing, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Tilray Medical, Bake Sale, The Batch, HEXO, Alpine Beer Company, Green Flash, Cruisies, Atwater Brewery, Hiball Energy, Liquid Love, Hop Valley Brewing, Redhook Brewery, Revolver Brewing, Square Mile Cider, Mock One, Widmer Brothers Brewing, Runner's High Brewing Company, SweetWater Brewing Company, Terrapin Beer Co., Happy Flower, Fizzy Jane's, Herb & Bloom, 420 Fizz, and Fresh Hemp Foods brands. The company sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$10.04
Mean price target
2. Current target
$6.75
Latest analyst target
3. DCF / Fair value
$-4.67
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$6.75
Low
$6.50
High
$24.00
Mean
$10.04

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-02 up Roth Capital Neutral → Buy $10
2026-03-30 main TD Cowen Buy → Buy $7
2026-01-20 main Roth Capital Neutral → Neutral $10
2025-08-25 main Jefferies Buy → Buy $2
2025-07-29 reit Zelman & Assoc Neutral → Neutral —
2025-04-09 main Piper Sandler Neutral → Neutral $1
2024-10-11 main Roth MKM Neutral → Neutral $2
2024-06-27 init Zuanic & Associates — → Neutral —
2024-04-10 main CIBC Neutral → Neutral $2
2023-09-01 reit Roth MKM Neutral → Neutral $3
2023-04-11 main TD Cowen — → Outperform $5
2023-01-10 main Alliance Global Partners — → Neutral $3
2022-11-02 init Bernstein — → Market Perform $4
2022-10-10 main Cantor Fitzgerald — → Neutral $5
2022-09-30 main Barclays — → Underweight $2
2022-08-02 main Cantor Fitzgerald — → Neutral $4
2022-07-29 down Benchmark Hold → Sell $3
2022-07-15 main Roth Capital — → Neutral $4
2022-06-24 main Cantor Fitzgerald — → Neutral $6
2022-06-15 main Canaccord Genuity — → Buy $7
News
RSS: Latest TLRY news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-21 HOPKINSON DAVID G. Director — 33,556 $6.94 $232,879
2026-01-07 COHEN STEVEN MICHAEL Director — 12,438 $8.99 $111,818
2025-07-31 MERTON CARL A. Chief Financial Officer — 93,928 $0.58 $54,478
2025-07-31 SIMON IRWIN DAVID Chief Executive Officer — 706,216 $0.58 $409,605
2025-07-31 GENDEL MITCHELL S General Counsel — 6,000 $0.58 $3,496
2025-07-31 GENDEL MITCHELL S General Counsel — 93,928 $0.58 $54,478
2025-07-31 FALTISCHEK DENISE M Officer — 93,928 $0.58 $54,478
2025-07-30 PERSOFSKY RENAH Director — 124,378 $0.61 $75,871
2025-07-30 MERTON CARL A. Chief Financial Officer — 33,500 $0.60 $19,939
2025-07-30 MERTON CARL A. Chief Financial Officer — 166,558 $0.61 $101,600
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Total Revenue
821.31
+4.10%
788.94
+25.80%
627.12
-0.20%
628.37
Operating Revenue
821.31
+4.10%
788.94
+25.80%
627.12
-0.20%
628.37
Cost Of Revenue
580.74
+2.68%
565.59
+17.79%
480.16
-6.14%
511.56
Reconciled Cost Of Revenue
535.87
+2.38%
523.43
+18.02%
443.50
-6.07%
472.15
Gross Profit
240.57
+7.71%
223.35
+51.98%
146.96
+25.80%
116.82
Operating Expense
348.38
+3.65%
336.11
+3.37%
325.15
-7.12%
350.08
Research And Development
0.28
-55.28%
0.64
-6.89%
0.68
-55.07%
1.52
Selling General And Administration
259.48
+3.49%
250.72
+8.55%
230.98
-1.02%
233.38
Selling And Marketing Expense
93.09
+17.58%
79.17
+20.36%
65.78
-0.13%
65.86
General And Administrative Expense
166.40
-3.01%
171.56
+3.84%
165.21
-1.38%
167.51
Salaries And Wages
112.30
-2.72%
115.44
+4.49%
110.48
+8.51%
101.81
Other Gand A
38.80
-0.38%
38.94
-1.51%
39.54
-10.95%
44.40
Total Expenses
929.12
+3.04%
901.70
+11.97%
805.32
-6.54%
861.64
Operating Income
-107.81
+4.39%
-112.76
+36.72%
-178.19
+23.61%
-233.27
Total Operating Income As Reported
-2,282.70
-1206.31%
-174.75
+87.24%
-1,369.68
-124.39%
-610.40
EBITDA
-2,127.55
-2820.74%
-72.84
+94.28%
-1,273.42
-416.81%
-246.40
Normalized EBITDA
19.43
+140.65%
-47.80
+84.73%
-312.97
-407.02%
101.94
Reconciled Depreciation
133.49
+5.18%
126.91
-2.49%
130.15
-15.81%
154.59
EBIT
-2,261.04
-1031.90%
-199.76
+85.77%
-1,403.57
-250.02%
-400.99
Total Unusual Items
-2,146.98
-8472.49%
-25.05
+97.39%
-960.45
-175.72%
-348.34
Total Unusual Items Excluding Goodwill
-2,146.98
-8472.49%
-25.05
+97.39%
-960.45
-175.72%
-348.34
Special Income Charges
-2,153.23
-11053.17%
-19.31
+97.96%
-945.16
-150.62%
-377.13
Other Special Charges
17.35
+110.24%
8.25
+1733.86%
-0.51
-104.04%
12.49
Impairment Of Capital Assets
2,096.14
0.00
-100.00%
934.00
+146.93%
378.24
Restructuring And Mergern Acquisition
38.82
+154.49%
15.25
+30.22%
11.71
+190.72%
-12.91
Net Income
-2,186.74
-792.62%
-244.98
+83.14%
-1,452.66
-204.67%
-476.80
Pretax Income
-2,302.37
-824.57%
-249.02
+82.83%
-1,450.18
-229.08%
-440.67
Net Non Operating Interest Income Expense
-29.95
+17.79%
-36.43
-168.15%
-13.59
+51.38%
-27.94
Interest Expense Non Operating
41.33
-16.10%
49.26
+5.69%
46.61
+17.47%
39.68
Net Interest Income
-29.95
+17.79%
-36.43
-168.15%
-13.59
+51.38%
-27.94
Interest Expense
41.33
-16.10%
49.26
+5.69%
46.61
+17.47%
39.68
Interest Income Non Operating
11.38
-11.32%
12.83
-61.15%
33.02
+181.40%
11.74
Interest Income
11.38
-11.32%
12.83
-61.15%
33.02
+181.40%
11.74
Other Income Expense
-2,164.61
-2068.32%
-99.83
+92.07%
-1,258.40
-601.20%
-179.46
Other Non Operating Income Expenses
-17.63
+76.43%
-74.78
+74.90%
-297.95
-276.43%
168.88
Gain On Sale Of Security
6.25
+208.90%
-5.74
+62.46%
-15.29
-153.09%
28.79
Tax Provision
-121.02
-354.68%
-26.62
-270.64%
-7.18
-9.77%
-6.54
Tax Rate For Calcs
0.00
-50.82%
0.00
+2058.38%
0.00
-66.64%
0.00
Tax Effect Of Unusual Items
-112.85
-4115.70%
-2.68
+43.71%
-4.76
+8.03%
-5.17
Net Income Including Noncontrolling Interests
-2,181.36
-880.81%
-222.40
+84.59%
-1,443.00
-232.39%
-434.13
Net Income From Continuing Operation Net Minority Interest
-2,186.74
-792.62%
-244.98
+83.14%
-1,452.66
-204.67%
-476.80
Net Income From Continuing And Discontinued Operation
-2,186.74
-792.62%
-244.98
+83.14%
-1,452.66
-204.67%
-476.80
Net Income Continuous Operations
-2,181.36
-880.81%
-222.40
+84.59%
-1,443.00
-232.39%
-434.13
Minority Interests
-5.38
+76.16%
-22.58
-133.81%
-9.66
+77.37%
-42.67
Normalized Income
-152.61
+31.45%
-222.61
+55.21%
-496.96
-271.89%
-133.63
Net Income Common Stockholders
-2,186.74
-792.62%
-244.98
+83.14%
-1,452.66
-204.67%
-476.80
Diluted EPS
-24.60
-645.45%
-3.30
+85.96%
-23.50
-161.11%
-9.00
Basic EPS
-24.60
-645.45%
-3.30
+85.96%
-23.50
-161.11%
-9.00
Basic Average Shares
89.03
+32.11%
67.40
+9.76%
61.40
+27.30%
48.24
Diluted Average Shares
89.03
+32.11%
67.40
+9.76%
61.40
+27.30%
48.24
Diluted NI Availto Com Stockholders
-2,186.74
-792.62%
-244.98
+83.14%
-1,452.66
-204.67%
-476.80
Amortization
88.62
+4.56%
84.75
-9.35%
93.49
-18.84%
115.19
Amortization Of Intangibles Income Statement
88.62
+4.56%
84.75
-9.35%
93.49
-18.84%
115.19
Depreciation Amortization Depletion Income Statement
88.62
+4.56%
84.75
-9.35%
93.49
-18.84%
115.19
Depreciation And Amortization In Income Statement
88.62
+4.56%
84.75
-9.35%
93.49
-18.84%
115.19
Earnings From Equity Interest
—
—
—
—
Gain On Sale Of PPE
-0.93
-122.11%
4.20
+8645.83%
0.05
-92.96%
0.68
Insurance And Claims
11.84
-5.90%
12.59
+4.60%
12.03
-31.38%
17.54
Rent And Landing Fees
3.45
-24.69%
4.58
+45.32%
3.15
-16.11%
3.76
Rent Expense Supplemental
3.45
-24.69%
4.58
+45.32%
3.15
-16.11%
3.76
Line Item Trend 2025-05-31
Total Assets
2,074.33
Current Assets
688.63
Cash Cash Equivalents And Short Term Investments
256.36
Cash And Cash Equivalents
221.67
Other Short Term Investments
34.70
Receivables
121.49
Accounts Receivable
121.49
Gross Accounts Receivable
125.19
Allowance For Doubtful Accounts Receivable
-3.70
Taxes Receivable
—
Inventory
270.88
Raw Materials
24.05
Finished Goods
151.98
Prepaid Assets
—
Assets Held For Sale Current
5.80
Other Current Assets
34.09
Total Non Current Assets
1,385.70
Net PPE
590.71
Gross PPE
827.01
Accumulated Depreciation
-236.29
Properties
0.00
Land And Improvements
44.53
Machinery Furniture Equipment
407.65
Construction In Progress
11.24
Other Properties
343.17
Leases
20.41
Goodwill And Other Intangible Assets
773.77
Goodwill
752.35
Other Intangible Assets
21.42
Investments And Advances
10.13
Long Term Equity Investment
—
Other Investments
—
Other Non Current Assets
11.08
Total Liabilities Net Minority Interest
584.75
Current Liabilities
280.30
Payables And Accrued Expenses
235.32
Payables
114.00
Accounts Payable
107.35
Current Accrued Expenses
121.32
Total Tax Payable
6.65
Income Tax Payable
0.06
Current Debt And Capital Lease Obligation
28.89
Current Debt
21.95
Other Current Borrowings
14.77
Current Capital Lease Obligation
6.94
Other Current Liabilities
16.09
Total Non Current Liabilities Net Minority Interest
304.45
Long Term Debt And Capital Lease Obligation
299.85
Long Term Debt
234.92
Long Term Capital Lease Obligation
64.92
Non Current Deferred Liabilities
3.75
Non Current Deferred Taxes Liabilities
3.75
Other Non Current Liabilities
0.85
Stockholders Equity
1,511.47
Common Stock Equity
1,511.47
Capital Stock
0.11
Common Stock
0.11
Preferred Stock
0.00
Share Issued
106.07
Ordinary Shares Number
105.87
Treasury Shares Number
0.20
Additional Paid In Capital
6,401.66
Retained Earnings
-4,847.23
Gains Losses Not Affecting Retained Earnings
-43.06
Treasury Stock
0.00
Minority Interest
-21.90
Other Equity Adjustments
-43.06
Total Equity Gross Minority Interest
1,489.58
Total Capitalization
1,746.39
Working Capital
408.32
Invested Capital
1,768.34
Total Debt
328.74
Net Debt
35.20
Capital Lease Obligations
71.87
Net Tangible Assets
737.70
Tangible Book Value
737.70
Available For Sale Securities
10.13
Interest Payable
4.19
Investmentin Financial Assets
10.13
Line Of Credit
7.18
Non Current Note Receivables
0.00
Notes Receivable
—
Other Inventories
94.86
Line Item Trend 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Operating Cash Flow
-94.60
-206.10%
-30.91
-490.91%
7.91
+104.46%
-177.26
Cash Flow From Continuing Operating Activities
-94.60
-206.10%
-30.91
-490.91%
7.91
+104.46%
-177.26
Net Income From Continuing Operations
-2,181.36
-880.81%
-222.40
+84.59%
-1,443.00
-232.39%
-434.13
Depreciation Amortization Depletion
133.49
+5.18%
126.91
-2.49%
130.15
-15.81%
154.59
Amortization Cash Flow
133.49
+5.18%
126.91
-2.49%
130.15
-15.81%
154.59
Depreciation And Amortization
133.49
+5.18%
126.91
-2.49%
130.15
-15.81%
154.59
Amortization Of Intangibles
133.49
+5.18%
126.91
-2.49%
130.15
-15.81%
154.59
Other Non Cash Items
30.32
-44.85%
54.98
-79.05%
262.44
+632.82%
-49.26
Stock Based Compensation
24.29
-23.54%
31.77
-19.77%
39.59
+10.00%
35.99
Asset Impairment Charge
2,096.14
0.00
-100.00%
989.00
+122.13%
445.24
Deferred Tax
-121.02
-211.32%
-38.87
-21.65%
-31.95
-16.03%
-27.54
Deferred Income Tax
-121.02
-211.32%
-38.87
-21.65%
-31.95
-16.03%
-27.54
Operating Gains Losses
-13.90
-154.33%
25.59
-45.88%
47.27
+122.47%
-210.39
Gain Loss On Investment Securities
3.39
-86.98%
26.03
-11.94%
29.55
+112.98%
-227.71
Net Foreign Currency Exchange Gain Loss
-18.22
-585.04%
3.76
-78.86%
17.77
-1.29%
18.00
Gain Loss On Sale Of PPE
0.93
+122.11%
-4.20
-8645.83%
-0.05
+92.96%
-0.68
Change In Working Capital
-62.56
-605.18%
-8.87
-161.61%
14.40
+115.69%
-91.77
Change In Receivables
-17.80
-170.74%
-6.58
-257.75%
4.17
+171.35%
-5.84
Changes In Account Receivables
-17.80
-170.74%
-6.58
-257.75%
4.17
+171.35%
-5.84
Change In Inventory
-13.56
+12.95%
-15.58
-20.44%
-12.93
+71.73%
-45.75
Change In Prepaid Assets
-8.26
-163.23%
13.07
+318.61%
3.12
-30.19%
4.47
Change In Payables And Accrued Expense
-22.94
-10919.81%
0.21
-98.94%
20.04
+144.89%
-44.65
Change In Payable
—
—
—
—
Change In Account Payable
—
—
—
—
Change In Other Working Capital
—
—
—
—
Investing Cash Flow
-46.72
-136.40%
128.35
+145.02%
-285.11
-1224.07%
-21.53
Cash Flow From Continuing Investing Activities
-46.72
-136.40%
128.35
+145.02%
-285.11
-1224.07%
-21.53
Net PPE Purchase And Sale
-26.09
-25.81%
-20.74
-25.73%
-16.50
+24.53%
-21.86
Purchase Of PPE
-32.92
-12.54%
-29.25
-40.62%
-20.80
+38.94%
-34.06
Sale Of PPE
6.82
-19.80%
8.51
+97.70%
4.30
-64.74%
12.21
Capital Expenditure
-32.92
-12.54%
-29.25
-40.62%
-20.80
+38.94%
-34.06
Net Investment Purchase And Sale
-2.52
-101.20%
209.72
+186.70%
-241.90
0.00
Purchase Of Investment
—
—
-241.90
0.00
Sale Of Investment
—
—
0.00
0.00
Net Business Purchase And Sale
-18.11
+70.13%
-60.63
-126.91%
-26.72
-8295.71%
0.33
Purchase Of Business
-18.11
+70.13%
-60.63
-126.91%
-26.72
—
Net Other Investing Changes
—
—
—
—
Financing Cash Flow
133.51
+277.57%
-75.19
-207.17%
70.16
-45.27%
128.20
Cash Flow From Continuing Financing Activities
133.51
+277.57%
-75.19
-207.17%
70.16
-45.27%
128.20
Net Issuance Payments Of Debt
-26.14
+68.81%
-83.81
-43.88%
-58.25
+52.85%
-123.55
Issuance Of Debt
3.45
-93.63%
54.17
-62.98%
146.34
0.00
Repayment Of Debt
-18.74
+85.87%
-132.63
+36.79%
-209.84
-57.83%
-132.95
Long Term Debt Issuance
3.45
-93.63%
54.17
-62.98%
146.34
0.00
Long Term Debt Payments
-18.74
+85.87%
-132.63
+36.79%
-209.84
-57.83%
-132.95
Net Long Term Debt Issuance
-15.29
+80.52%
-78.46
-23.55%
-63.50
+52.24%
-132.95
Short Term Debt Issuance
—
—
5.26
-44.10%
9.41
Net Short Term Debt Issuance
-10.85
-102.92%
-5.35
-201.71%
5.26
-44.10%
9.41
Net Common Stock Issuance
161.19
+1770.15%
8.62
-93.29%
128.40
-49.41%
253.82
Common Stock Payments
0.00
0.00
+100.00%
-1.19
+86.31%
-8.69
Repurchase Of Capital Stock
0.00
0.00
+100.00%
-1.19
+86.31%
-8.69
Proceeds From Stock Option Exercised
—
0.00
0.00
-100.00%
5.40
Net Other Financing Charges
-1.54
—
—
-7.48
Changes In Cash
-7.81
-135.09%
22.26
+110.75%
-207.05
-193.27%
-70.60
Effect Of Exchange Rate Changes
1.14
+307.10%
-0.55
+75.38%
-2.23
-13.89%
-1.96
Beginning Cash Position
228.34
+10.51%
206.63
-50.32%
415.91
-14.85%
488.47
End Cash Position
221.67
-2.92%
228.34
+10.51%
206.63
-50.32%
415.91
Free Cash Flow
-127.52
-111.98%
-60.15
-366.53%
-12.89
+93.90%
-211.33
Income Tax Paid Supplemental Data
—
—
—
—
Common Stock Issuance
161.19
+1770.15%
8.62
-93.35%
129.59
-50.63%
262.51
Issuance Of Capital Stock
161.19
+1770.15%
8.62
-93.35%
129.59
-50.63%
262.51
Sale Of Business
—
—
—
0.33
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category